05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 1
ARDS
BYDR MUHAMMAD AKRAM
MATERNITY AND CHILDREN HOSPITALMAUSADIA, JEDDAH
RESIDENT ICU
INTRODUCTION
In 1967 the investigators from university of Colorado presented the modern concept of ARDS.
A type of Acute Respiratory failure of noncardiac origin.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 2
What is ARDS?
Definition formalized in 1992 American European Consensus Conference
1. Acute onset, bilateral infiltrates on CXR
2. PCWP ≤ 18 mmHg or no clinical evidence of left atrial hypertension
3. PaO2/FiO2 (P/F) Ratio ≤ 300 for ALI ≤ 200 for ARDS
Bernard et al. AJRCCM 1994;149:818-824
What is ARDS? – Berlin Definition
The ARDS Definition Task Force. JAMA 2012;307:2526-2533
CLINICAL FEATURES
The clinical features of ARDS usually appear within 6 to 72 hours of an inciting event and worsen rapidly
Patients typically present with dyspnea cyanosis (ie, hypoxemia) diffuse crackles.
Respiratory distress is usually evident, including tachypnea, tachycardia, diaphoresis, and use of accessory
muscles of respiration. A cough and chest pain may also exist.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 5
CLINICAL FEATURES
Arterial blood gases reveal hypoxemia High concentrations of supplemental oxygen are generally
required to maintain adequate oxygenation. The initial chest radiograph typically has bilateral alveolar
infiltrates computed tomography (CT) usually reveals widespread
patchy or coalescent airspace opacities that are usually more apparent in the dependent lung zones.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 6
EPIDEMIOLOGY
The incidence of ARDS in the United States . Within intensive care units,
approximately 10 to 15 percent of admitted patients and up to 20 percent of mechanically ventilated patients meet criteria for ARDS .
The incidence of ARDS may be somewhat higher in the United States than in other countries .
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 8
OUT COME
Mortality varies from 40 to 60%. Most die of non respiratory complication
during the supportive phase of ARDS rather then hypoxia
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 9
COMPLICATIONS
BarotraumaDeliriumNosocomial infection
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 10
PATHOPHYSIOLOGY
• Endothelial injury– Endothelin-1, VWF
• Epithelial injury • Neutrophil-mediated injury
– Near endothelium, retained, activated • Cytokines – TNF, IL-1, IL-8 • Oxidative injury • Ventilator-induced injury • Hypercoagulability • Fibrosis
Ware LB. Sem in Resp Crit Care Med 2006
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 11
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 12
Pathology
Like interstitial nephritis and acute hepatitis, the term ARDS encompasses many distinct disorders that share common clinical and pathophysiologic features.
The pathological features of ARDS are typically described as passing through three overlapping phases: exudative, proliferative and finally fibrotic phase.
PATHOLOIC FEATURES
Depend on the time of tissue sampling As the clinical disorder unfolds, there is
histologic evidence of diffuse alveolar damage
Features include Presence of microthrombi of platelets and
WBCs within capillary lumen, denudation of epithelial lining cells, swelling of the capillary endothelial cells, infiltration by polymorph nuclear leukocytes(PMNLs), and hyaline membrane formation within alveoli
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 14
Pathogenesis
Lung injury is primarily initiated by a specific insult (sepsis, trauma, VILI); with the initiation of inflammation there is rapid and increased recruitment of leucocytes, together with inflammatory mediators to the site of injury, several mechanisms had been involved in the pathogenesis of ARDS.
Pathogenesis
MANAGEMENT
Guidelines for ventilatory support of the patient with ARDS from the ACCP Consensus Conference on Mechanical Ventilation include the following: 1. Clinicians should choose a ventilatory mode that is
capable of supporting oxygenation and ventilation and one with which they are familiar.
2. Oxygenation target is arterial oxygen saturation of >90%.
3. End-inspiratory plateau pressures of >35 cm H2O are a concern for the development of alveolar overdistention. In this setting, clinicians ought to consider decreasing the tidal volume to values as low as 5 mL/kg.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 18
MANAGEMENT
4. To meet target end-inspiratory pressure goal, the PaCO2 may be permitted to rise as long as there is no evidence of increased intracranial pressure or other contraindication to permissive hypercapnia.
5. Positive end-expiratory pressure (PEEP) is beneficial in supporting oxygenation; however, the level of PEEP support used should be minimized and continually evaluated.
6. The goal for FIO2 is to achieve adequate oxygenation with the least amount of supplemental oxygen. Attempts should be made to decrease the FIO2 to levels <0.55, if possible. The use of PEEP may assist with the reduction in oxygen support.
7. When oxygenation is inadequate, clinicians ought to consider the use of sedation, paralysis, or position changes and strategies to increase tissue oxygen delivery.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 20
MANAGEMENT STEPS
Removal of precipitating/ underlying cause
Ventilatory support Oxygenation with min. ventilatory
trauma Low tidal volumes of 05 to 07 mls./ kg. Limit inspiratory pressure of <35
cmH2O Permissive hypercapnia ?? Permissive hypoxia pO2 55-65
mmHg
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 21
MANAGEMENT TECHNIQUES
Alveolar recruitment PEEP inc. Pa O2 with min. FiO2 (10-20
cm) Ventilatory facilitated recruitment
techniques Physiotherapy Ventilation strategies Inverse ratio / newer modes Nitric Oxide PRONE VENTILATION 05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 22
Adjuncts to Improve Survival
Daily spontaneous breathing trials Daily discontinuation of sedation Avoiding neuromuscular blocakde DVT prophylaxis HOB elevation Stress ulcer prophylaxis Enteral nutrition (when possible)
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 23
OTHER MANAGEMENT OPTION
Steroids Surfactant PDE inhibitors Extrapulmonary gas exchange:-
IVOX ( Intra Venacaval gas exchange) ECMO ( Extra Carporeal Membrane
Oxygenation) ECCO2- R ( Extra Carporeal CO2 Removal)
Ketoconazole Prostaglandin inhibitors.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 24
PERMISSIVE HYPERCAPNIA
TV is reduced to allow ventilation at lower peak airway pressure and less risk of volutrauma
This approach may allow better oxygenation but leads to hypercapnia
Gradual elevation of PaCO2 about 2.5mmHg/hr is well tolerated
Acute elevation in PaCO2 leads to Increased Sympathetic activity Raised Cardiac Output High pulmonary vascular resistance Impaired skeletal and bronchomotor tone Dialated cerberal vessels Impaired CNS function
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 25
SURFACTANT THERAPY
It is produced by type 2 pneumocytes, decreases surface tension at the air-fluid interface of small airways and alveoli
Without surfactant the alveoli may collapse and resist opening, even high airway pressures
Plasma protein leak into the alveolar airspaces inactivate the existing surfactant
Resulting increasing surface tension leads to Atelactesis and decreased lung compliance
Newer preparation in current clinical trial
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 26
NITRIC OXIDE
A powerful endogenous vasodilator Because it is rapidly inactivated, its
effects are restricted to the blood vessels at the site of administration
Inhalation dilates pulmonary vessels perfusing aerated lung units, diverting blood flow from poorly ventilated or shunt regions
An ideal agent to treat Pulmonary Hypertension and ARDS
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 27
INVERSE RATIO VENTILATION
Inspiratory phase is prolonged and leads to an increase in inspiration-to-expiration ratio ( between 1:1 and 4:1 )
This approach increases the mean airway pressure maintaining acceptable peak airway pressure
Disadvantages of IRV include air trapping leading to auto PEEP. Therefore, requires heavy sedation and neuromuscular blocked
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 28
POSITIVE END-EXPIRATORY PRESSURE ( PEEP )
It is the pressure maintained in the lungs at the end of expiration
Prevents collapse of alveoli, thus increases the surface area of O2 transfer
High level causes over distension of the alveoli, poor lung compliance, increase in the airway pressures, and deleterious effect on cardiac out put
“BEST PEEP” is a balance between the advantages and disadvantages of PEEP
Recommendation are to start with PEEP of 5cm H2O and increase by 03 to 05 cm H2O to achieve Oxygen saturation >/=90%
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 29
TRACHEAL GAS INSUFFLATION
Physiologic dead space is elevated in ARDS, and small tidal volume ventilation causes hypercapnia and acute acidosis
With TGI, a stream of fresh gas ( approximately 04 to 08 L/min. ) is insufflated through a small catheter or through small channels in the wall of the ETT into lower trachea, flushing CO2- laden gas out prior to next inspiration
It can be used throughout respiratory cycle ( continuous flow catheter ) or only during a segment of it ( Phasic catheter flow )
Disadvantage include:- Auto PEEP Catheter may become nidus for infection Desiccation of secretions and airway mucosal injury
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 30
FLUOROCARBON LIQUID-ASSISTED VENTILATION
Surface tension can be eliminated by filling the lungs with a liquid such as fluorocarbon.
It can dissolve O2 17 times more O2 than water, has low surface tension and spreads quickly over the respiratory epithelium, and evaporates
Requires a liquid-gas exchange device to oxygenate liquid, deliver the tidal volume, and remove CO2
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 31
EXTRAPULMONARY GAS EXCHANGE
Reduces the requirement for ventilating pressure
Methods include ECMO ECCO2-R IVOX
There has been 50% mortality reported comparing to 90% in a control group by Gatinoni in 1986. Approximately same stands for study by Brunet while patients were treated with low-frequency positive-pressure ventilation ( LFPPV )
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 32
ECMO
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 33
GLUCOCORTICOID THERAPY
High dose of glucocorticoids do not prevent the development of ARDS in patients with sepsis
Serum complement level are not lowered in patients with sepsis induced ARDS
Patients with late- phase of ARDS have persistent inflammation, with cytokines release in the airspaces in lungs, glucocorticoids at this stage could facilitate recovery.
Increase the risk of nosocomial infection, which could diminish the chances of recovery
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 34
PROSTAGLANDIN AGONISTS/ INHIBITORS
Ketoconazole, a potent inhibitor of thromboxane and leukotriene synthesis, prevent the development of ARDS
Prostaglandin E1 is a vasodilator that blocks platelet aggregation and decreases neutrophil activation
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 35
PRONE POSITIONING FOR ARDS
Indications: Pulmonary dysfunction despite
escalating mechanical ventilatory support
Goals of Ventilation: SaO2 >92% PaO2/FiO2 ≥200 pH 7.25 – 7.40 Pplat <35 cm H2O
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 36
PRONE POSITIONING FOR ARDS
Criteria for Inclusion: CXR with diffuse bilateral infiltrates
consistent with ALI or ARDS Mechanical ventilation
FiO2 ≥ 0.6 for 48 hours PEEP ≥ 15 cm for 48 hours (includes PCIRV,
auto PEEP) Increasing respiratory dysfunction as
evidenced by: PaO2/FiO2 < 200
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 37
PRONE POSITIONING FOR ARDS
Exclusion Criteria: Closed head injury with ICH Unstable orthopedic fracture Spinal cord injury Hemodynamic instability Active intraabdominal process Pregnancy
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 38
PRONE POSITIONING FOR ARDS
Procedure: Order from Attending doctor ETCO2 monitor and arterial line in-place. Low air-loss mattress. Discontinue gastric feeding. Stomach to
be evacuated via NGT. Explanation of procedure to patient and
family Minimum of 3 RNs, Attending doctor, and
RT.
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 39
PRONE POSITIONING FOR ARDS
Reposition ECG leads to patient’s back. Anticipate the need for frequent ETT
suctioning. Obtain ABG 20 minutes after
repositioning. Duration of prone positioning is
dependent upon patient’s hemodynamic status
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 40
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 41
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 42
Transfusion-Related Acute Lung Injury
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 44
Respiratory distress, pulmonary edema, hypoxia,hypotension and fever• Within 2 hours of transfusion (6 at most)• Mechanism– Plasma in transfused product– HLA antibodies or granulocyte specific antibodies• 1/5000?• 5-10% mortality• Diagnosis:– Difficult to tease out– Isolation of antibodies
Popovsky et al. Guidelines for the management of TRALI. AABB 2003
Transfusion-Related Acute Lung Injury
05/02/2023DR. MUHAMMAD AKRAM KHAN QAIM KHANI 46
Stop the transfusion• Treat pulmonary and cardiac dysfunction• Test the transfused units• Contact a reference lab for advice• Subsequent transfusions to that individualnot a problem